tislelizumab
beigene
[]
and now tislelizumab plus chemo showed better os, pfs and orr in pts with gastric cancers or gej adenoc and pd-l1 score &gt;5% .. love this meeting #gi23 #asco 
Medical Oncologist, GI tumors and NET, @INCMNSZ